The effect of Lactobacillus reuteri on pulmonary function test and growth of cystic fibrosis patients
Journal of the Science of Food and Agriculture · 2024
DOI: 10.1002/jsfa.13732 ↗Kurz gefasst
Randomisierte kontrollierte Studie in der Zeitschrift Journal of the Science of Food and Agriculture, 2024. Verfasst von Seyed Ahmad Tabatabaii und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pediatric Pulmonology, Mofid Children's Hospital, Shahid Beheshti University of Medical Sciences, Tehran, Iran. Hauptthemen laut MEDLINE: Cystic Fibrosis, Limosilactobacillus reuteri, Probiotics, Respiratory Function Tests. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 43 Literaturangaben.
Abstract (Originalsprache)
INTRODUCTION Cystic fibrosis (CF) patients frequently experience gut microbiota dysbiosis. Probiotic supplementation is a potential therapeutic approach to modify gut microbiota and improve CF management through the gut–lung axis. The aim of this study was to investigate the effect of Lactobacillus reuteri supplementation on pulmonary function test, respiratory symptoms and growth in CF patients. METHODS A randomized, placebo‐controlled clinical trial was carried out on 40 children with CF aged from 6 to 20 years. Participants were designated to receive either L. reuteri or placebo daily for 4 months. Pulmonary function tests, weight, height and body mass index (BMI) z ‐scores were measured pre and post treatment. RESULTS The median baseline BMI of the patients was 16.28 kg m −2 . A significant change in the probiotic group's BMI z ‐score after the study period was observed ( P = 0.034) but not for weight and height z ‐scores ( P > 0.05). After treatment, Pseudomonas aeruginosa grew in sputum cultures of seven in the placebo and one patient in the intervention group ( P = 0.03) while at baseline it grew in the sputum of four patients in each group. There was no significant difference in forced expiratory volume in the first second, forced expiratory flow at 25–75% or forced vital capacity change between the two groups after the treatment period ( P > 0.05). Additionally, no significant differences were found in pulmonary exacerbations, hospitalization frequencies or COVID‐19 infection between the two groups during the study ( P > 0.05). CONCLUSION The results suggest that L. reuteri supplementation may impact the growth of severely malnourished CF patients. Furthermore, it may be concluded that this strain might reduce P. aeruginosa in the sputum culture of CF patients. © 2024 Society of Chemical Industry.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Pediatric Pulmonology, Mofid Children's Hospital, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
- Children Growth Disorder Research Center, Shahid Sadoughi University of Medical Sciences, Yazd, Iran.
- Pediatric Gastroenterology, Hepatology and Nutrition Research Center, Research Institute for Children's Health, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
ORCID-Profile: Seyedeh Zalfa Modarresi
Zitieren
APA
Tabatabaii, S. A., Khanbabaee, G., Sadr, S., Farahbakhsh, N., Modarresi, S. Z., Pourghasem, M., & Hajipour, M. (2024). The effect of Lactobacillus reuteri on pulmonary function test and growth of cystic fibrosis patients. Journal of the Science of Food and Agriculture. https://doi.org/10.1002/jsfa.13732
Vancouver
Tabatabaii SA, Khanbabaee G, Sadr S, Farahbakhsh N, Modarresi SZ, Pourghasem M, et al. The effect of Lactobacillus reuteri on pulmonary function test and growth of cystic fibrosis patients. Journal of the Science of Food and Agriculture. 2024. doi:10.1002/jsfa.13732
BibTeX
@article{Tabatabaii2024,
author = {Tabatabaii, Seyed Ahmad and Khanbabaee, Ghamartaj and Sadr, Saeed and Farahbakhsh, Nazanin and Modarresi, Seyedeh Zalfa and Pourghasem, Matin and Hajipour, Mahmoud},
title = {The effect of Lactobacillus reuteri on pulmonary function test and growth of cystic fibrosis patients},
journal = {Journal of the Science of Food and Agriculture},
year = {2024},
doi = {10.1002/jsfa.13732}
}
EUVIMED